NGHIÊN CỨU ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ BỆNH NHÂN HO RA MÁU BẰNG PHƯƠNG PHÁP CAN THIỆP NỘI MẠCH MẠCH MÁU SỐ HÓA XÓA NỀN (DSA) TẠI BỆNH VIỆN ĐA KHOA TRUNG ƯƠNG CẦN THƠ NĂM 2022–2023

Abstract

Background: Hemoptysis is a common clinical emergency of respiratory and cardiovascular diseases, causing high mortality. Currently, endovascular intervention is a technique used diagnosis and treatment of hemoptysis. However, the treatment outcome by digital subtraction angiography can be varied depending on the clinical and subclinal conditions and other technical factors. Objectives: To survey of clinical, subclinical features of patients with hemoptysis and evaluate the treatment outcomes of the patients by digital subtraction angiography at Can Tho Central General Hospital. Materials and methods: A cross-sectional, prospective study was carried out of 33 patients were diagnosed and underwent endovascular intervention guided by digital subtraction angiography to treat hemoptysis at Can Tho Central General Hospital from April 2022 to April 2023. Results: The highest rate for background history was pulmonary tuberculosis (48.5%). The most accompanying symptoms was pulmonary rales (66.7%), dyspnea (33.3%). Respiratory failure accounted for 15.2%. 87.9% of patients had recorded chest x ray abnormalities; 93.9% had specific lesions on chest Computer tomography; 100% had a change in the shape of the bronchial artery, and the main artery causing hemoptysis was the right bronchial artery, accounting for 69.7%. 97% of patients were successfully treated, 3% (1 patient) relapsed early. Complications after digital subtraction angiography included chest pain (24.2%). The most common cause of hemoptysis is bronchiectasis, accounting for 39.4%. Conclusion: Digital subtraction angiography was demonstrated as an effective and safe technique for hemoptysis treatment.